Skip to contentSkip to filters

We use cookies for analytics.

Topic: Cobalamin-C defect

ePoster
1 ePoster

In Neuroscience

Exploring the potential of readthrough drugs on MMACHC nonsense mutation R132* responsible for cobalamin C defect

Gursimran Kaur, Rajdeep Kaur, Savita Verma Attri, Indu Verma, Arushi Gahlot Saini, Rajesh Gupta · FENS Forum 2024

Cobalamin-C defect is the most common inborn error of intracellular cobalamin metabolism. The nonsense mutation, c.394C>T (R132*), resulting in truncated protein, was common in North Indian cohort. Based on the location of mutation, it can be targeted for readthrough drug therapeutics for restoring the MMACHC activity. We created stable mammalian cell lines expressing wildtype (WT) and mutant (R132*) MMACHC protein to check the efficacy of readthrough drugs. WT cDNA clone of MMACHC gene was purchased and mutant clone (R132*_MMACHC) was prepared by site-directed mutagenesis. WT and R132*_MMA

ePoster · Neuroscience